C22.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for the study was the decision for TACE by the local interdisciplinary tumor board as defining the lesion as not eligible for liver transplantation, surgery, or local ablative treatments in correlation to the recommendations of the "European Association for the Study of the Liver".
Exclusion criteria
Exclusion criteria: Contraindication for DEB TACE were a plasma creatinine level above 2.0 mg/mL, an international normalized ratio (INR) above 2.0, a bilirubin level above 2.0 mg/dl, and a more than five-fold increase in transaminase levels.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the data collected by the image processing software with the "modified response evaluation criteria in solid tumors". For this purpose, the image data immediately before the intervention and the image data after the intervention for the therapy evaluation are compared with the periprocedural image data. | — |
Countries
Germany
Contacts
Universitätsklinikum MannheimInstitut für klinische Radiologie und Nuklearmedizin